EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Predominance of DENV-3 among patients in Ouagadougou, Burkina Faso

Abdoul Karim Ouattara, Shoukrat Ohuwa Toyin Bello, Alphonsine Ouédraogo, Lassina Traoré, Florencia Wendkuuni Djigma, Jacques Simporé

Journal of Vector Borne Diseases · 2025

DOI: 10.4103/jvbd.jvbd_68_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vector Borne Diseases, 2025. Verfasst von Abdoul Karim Ouattara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche Biomoléculaire Pietro Annigoni (CERBA), Ouagadougou, Burkina Faso. Hauptthemen laut MEDLINE: Dengue, Dengue Virus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives: Dengue is an emerging vector-borne viral disease in tropical and subtropical areas such as Burkina Faso that experienced dengue outbreak in, 2013, 2016, 2017 and more recently in 2023. This study aimed to determine the seroprevalence and dengue serotype in suspected patients in Ouagadougou, Burkina Faso.

Methods

The study was conducted during October and November 2023 and included suspected febrile patients seen at HOSCO and CERBA. Plasma or serum samples were used for the detection of non-structural proteins (NS1) and IgM and IgG antibodies against the dengue virus using SD Bioline Dengue Duo rapid detection kit. Viral RNA was extracted using the QIAamp Viral RNA Mini Kit and dengue serotypes were determined by real-time RT-PCR using the Dengue Real-TM Genotype kit.

Results

The study population consisted of 896 patients, including 397 (44.3%) men and 499 (55.7%) women. Dengue seroprevalence was 16.5% (148/896) with 14.1% (126/896) of patients positive for the NS1 antigen, 1.3% (12/896) positive for IgM, and 2.7% (24/896) positive for IgG. Serotyping among 40 out of 45 positive patients revealed 77.5% (31/40) DENV-3, 17.5% (7/40) DENV-1, and 5.0% (2/40) DENV-2. Interpretation & conclusion: The present study reports a high seroprevalence of dengue virus infection among patients during the months considered as the peak of infection in Burkina Faso. The results revealed a predominance of DENV-3. Continuous surveillance of dengue virus serotypes circulating in Burkina Faso is crucial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DengueDengue VirusHumansBurkina FasoFemaleMaleAdultAntibodies, ViralSeroepidemiologic StudiesMiddle AgedYoung AdultAdolescentImmunoglobulin MImmunoglobulin GChildChild, PreschoolSerogroupAgedRNA, ViralInfantViral Nonstructural Proteins

Stichwörter der Autor:innen

Burkina FasoDengue virusIgGIgMNS1Serotypes

Substanzen

Antibodies, ViralImmunoglobulin MImmunoglobulin GRNA, ViralViral Nonstructural Proteins

Autor:innen und Institutionen

  • Centre de Recherche Biomoléculaire Pietro Annigoni (CERBA), Ouagadougou, Burkina Faso.
  • Université Norbert Zongo/Centre Universitaire de Manga, Koudougou, Burkina Faso.
  • Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE), Université Joseph KIZERBO, Ouagadougou, Burkina Faso.

Zitieren

APA

Ouattara, A. K., Toyin Bello, S. O., Ouédraogo, A., Traoré, L., Djigma, F. W., & Simporé, J. (2025). Predominance of DENV-3 among patients in Ouagadougou, Burkina Faso. Journal of Vector Borne Diseases. https://doi.org/10.4103/jvbd.jvbd_68_24

Vancouver

Ouattara AK, Toyin Bello SO, Ouédraogo A, Traoré L, Djigma FW, Simporé J. Predominance of DENV-3 among patients in Ouagadougou, Burkina Faso. Journal of Vector Borne Diseases. 2025. doi:10.4103/jvbd.jvbd_68_24

BibTeX
@article{Ouattara2025,
  author = {Ouattara, Abdoul Karim and Toyin Bello, Shoukrat Ohuwa and Ouédraogo, Alphonsine and Traoré, Lassina and Djigma, Florencia Wendkuuni and Simporé, Jacques},
  title = {Predominance of DENV-3 among patients in Ouagadougou, Burkina Faso},
  journal = {Journal of Vector Borne Diseases},
  year = {2025},
  doi = {10.4103/jvbd.jvbd_68_24}
}
Kostenlos starten →